Drug intelligence / Profile preview

Ac-GlcNAc-5S

Development stage
Preclinical
Lead developer
Drexel University
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Ac-GlcNAc-5S (also known as 5S-GlcNAc or peracetylated 5-thio-GlcNAc) is a cell-permeable small molecule inhibitor of O-GlcNAc transferase (OGT). Chemically, it is a thio-sugar analog of N-acetylglucosamine (GlcNAc) where the pyranose ring oxygen is substituted with sulfur. Upon entering the cell, it is deacetylated and converted into UDP-5S-GlcNAc, which acts as a potent competitive inhibitor of OGT. In the context of oncology research, particularly glioblastoma, Ac-GlcNAc-5S has been shown to disrupt acetate metabolism by preventing the O-GlcNAcylation-dependent stabilization of ACSS2, thereby reducing tumor growth and lipid synthesis. It is primarily utilized as a chemical biology tool to investigate the role of O-linked β-N-acetylglucosamine (O-GlcNAc) post-translational modifications in various disease states, including cancer and neurodegeneration.

Other names
peracetylated 5-thio-GlcNAcperacetylated5-thio-GlcNAcperacetylated-5-thio-GlcNAc5-thio-N-acetylglucosamine
02

Targets

UDP-GlcNAc-dependent glycosyltransferasesOGT (UDP-N-acetylglucosamine—peptide N-acetylglucosaminyltransferase)

Beyond the preview

Go deeper on Ac-GlcNAc-5S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ac-GlcNAc-5S.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call